Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing
Publication/Presentation Date
6-1-2022
Abstract
OBJECTIVES: The widespread intestinal carriage of ESBL-producing
METHODS: Our systematic review included 133 articles published between 1 January 2000 and 22 April 2021 and indexed in PubMed, EMBASE or Google Scholar. A random-effects meta-analysis was performed to obtain the global pooled prevalence (community and healthcare settings). Subgroup meta-analyses were performed by grouping studies using the WHO regions and 5 year intervals of the study period.
RESULTS: We found that 21.1% (95% CI, 19.1%-23.2%) of inpatients in healthcare settings and 17.6% (95% CI, 15.3%-19.8%) of healthy individuals worldwide carried ESBL
CONCLUSIONS: The global and regional human intestinal ESBL
Volume
4
Issue
3
First Page
048
Last Page
048
ISSN
2632-1823
Published In/Presented At
Bezabih, Y. M., Bezabih, A., Dion, M., Batard, E., Teka, S., Obole, A., Dessalegn, N., Enyew, A., Roujeinikova, A., Alamneh, E., Mirkazemi, C., Peterson, G. M., & Bezabhe, W. M. (2022). Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli between healthcare and community settings: a systematic review and meta-analysis. JAC-antimicrobial resistance, 4(3), dlac048. https://doi.org/10.1093/jacamr/dlac048
Disciplines
Medicine and Health Sciences
PubMedID
35668909
Department(s)
Department of Medicine, Cardiology Division, Fellows and Residents
Document Type
Article